Population implications of changes in lipid management in patients with coronary heart disease


      Pharmacologic treatment and goal attainment rates from published literature indicate that lipid management has generally improved for patients with coronary heart disease. The population implications of these changes in lipid management are examined, suggesting that the challenge of lipid management may be shifting from a problem of no treatment to one of undertreatment.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sueta C.A.
        • Chowdhury M.
        • Boccuzzi S.
        • Smith S.C.
        • Alexander C.M.
        • Londhe A.
        • Lulla A.
        • Simpson R.J.
        Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.
        Am J Cardiol. 1999; 83: 1303-1307
        • Olson K.
        • Bungard T.
        • Tsuyuki R.
        Cholesterol risk management.
        Pharmacotherapy. 2001; 21: 807-817
        • Straka R.
        • Taheri R.
        • Cooper R.
        • Tan A.
        • Smith J.
        Assessment of hypercholesterolemia control in a managed care organization.
        Pharmacotherapy. 2001; 21: 818-827
        • Pearson T.
        • Peters T.
        • Feury D.
        Comprehensive risk reduction in coronary patients.
        Circulation. 1997; 96: I-733
        • Latts L.
        Assessing the results.
        Am J Med. 2001; 110: 17S-23S
        • NCEP Expert Panel
        Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
      1. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988–1994, Reference Manuals and Reports: Manual for Medical Technicians and Laboratory Procedures Used for NHANES III [book on CD ROM]. Hyattsville, MD: Centers for Disease Control and Prevention, 1996

        • Hunninghake D.B.
        • Stein E.A.
        • Dujovne C.A.
        • Harris W.S.
        • Feldman E.B.
        • Miller V.T.
        • Tobert J.A.
        • Laskarzewski P.M.
        • Quiter E.
        • Held J.
        • et al.
        The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.
        N Engl J Med. 1993; 328: 1213-1219
        • Caggiula A.Q.
        • Watson J.E.
        • Kuller L.H.
        • Olson M.B.
        • Milas N.C.
        • Berry M.
        • Germanowski J.
        Cholesterol-lowering intervention program.
        Arch Intern Med. 1996; 156: 1205-1213